Relypsa Stock Price (NASDAQ:RLYP)

Add to My Stocks
$31.99 $0 (0%) RLYP stock closing price Sep 01, 2016 (Closing)
Prev Close* : $31.99
Market Cap:
$1.44B
Day Low: $0
52 Week Low: $10.26
Open: $0
Volume: $107
Day High: $0
52 Week High: $32.12
Dividend:
0.00

Latest Stock Market News

Latest Articles

Relypsa News - From Partners

RLYP Stockcharts

View RLYP PE ratio, PS ratio stocks charts and compare with peers.
RLYP Chart
Note: Compare Relypsa stock price history with the index and industry peers.

Relypsa Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
)
PB ratio (
price to book ratio
)

Relypsa Returns

ROE
(return on equity)

Relypsa Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

RLYP Industry Peers

Company Price Change (%)
Akorn (AKRX)19.480.49 (2.58%)
Supernus Pharma (SUPN)44.40.4 (0.89%)
Ardelyx (ARDX)4.10.15 (3.8%)
Glycomimetics (GLYC)15.380.87 (6%)
Geron (GERN)3.940.02 (0.51%)
Cardinal Health (CAH)51.750.15 (0.29%)
Mckesson (MCK)130.651.27 (0.98%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teva Pharmaceutical (TEVA)25.651.43 (5.9%)
Mallinckrodt (MNK)36.071.38 (3.98%)
Allergan (AGN)190.755.15 (2.77%)
Akorn (AKRX)19.480.49 (2.58%)
BAUSCH HEALTH (BHC)22.320.43 (1.96%)
Dr. Reddy's Laboratories (RDY)34.220.39 (1.15%)
Mylan (MYL)38.410.26 (0.68%)
Top gainers from Medical-Generic Drugs industry
* As of Aug 21, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)21.840.59 (2.63%)
Progenics Pharma (PGNX)7.670.14 (1.79%)
Supernus Pharma (SUPN)44.40.4 (0.89%)
Corium (CORI)8.890.04 (0.45%)
Top losers from Medical-Generic Drugs industry
* As of Aug 21, 2018

Relypsa Inc Stock News - Partner Headlines

Relypsa Financial Statements

income statement20152014201320122011
Net Sales or Revenues18.55M----
Net Income-178.71M-79.88M-73.84M-43.72M-25.82M
Total Operating Expense196.42M78.13M70.91M43.33M25.52M
View Relypsa income statement
balance sheet20152014201320122011
Total Assets278.32M151.83M106.03M64.13M30.48M
Total Liabilities93.45M33.37M31.18M34.07M3.91M
Shareholders Equity184.87M118.46M74.85M30.05M26.57M
View Relypsa balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) in Assets Liabilities44.57M-6.92M4.12M6.17M-
Net Cash from (used by) Operating Activities-110M-70.86M-62.64M-35.51M-23.56M
Increase (Decrease) in Prop Plant And Equipment-8.94M-2.59M-3.77M-2.65M-0.15M
View Relypsa cash flow statement

Relypsa Stock Message Board

Relypsa stock price ended the last trading day at $31.99. Stock price or share price can be used to find the total market value of a company. Relypsa market cap stands at $1.44B as of Sep 01, 2016. Relypsa valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Relypsa stock price and Relypsa share price mean the same thing. 107 shares were traded with a closing stock price of $31.99 as of Sep 01, 2016, as can be seen from Relypsa stock quote. One can view Relypsa stock chart to follow the stock price trend. Relypsa paid 0.00 stock dividends to its shareholders during last quarter. Relypsa stock price history, gives the entire historical data for RLYP stock.